A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis
Nature Publishing Group UK
MetadataShow full item record
Tsukiyama, T., Zou, J., Kim, J., Ogamino, S., Shino, Y., Masuda, T., Merenda, A., et al. (2020). A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis. Nature Communications, 11 (1) https://doi.org/10.1038/s41467-020-18257-3
Funder: Japan Foundation for Applied Enzymology; doi: https://doi.org/10.13039/100008695
Funder: Pancreas Research Foundation of Japan Collaborative Research Project Program of the Medical Institute of Bioregulation, Kyushu University, Japan Joint Research Program of the Institute for Molecular and Cellular Regulation, Gunma University, Japan Grant for Joint Research Project of the Research Institute for Microbial Diseases Osaka University
Funder: European Research Council (ERC (639050) and the Interpark Bio-Convergence Center Grant Program.
Abstract: Frequent mutation of the tumour suppressor RNF43 is observed in many cancers, particularly colon malignancies. RNF43, an E3 ubiquitin ligase, negatively regulates Wnt signalling by inducing degradation of the Wnt receptor Frizzled. In this study, we discover that RNF43 activity requires phosphorylation at a triplet of conserved serines. This phospho-regulation of RNF43 is required for zebrafish development and growth of mouse intestinal organoids. Cancer-associated mutations that abrogate RNF43 phosphorylation cooperate with active Ras to promote tumorigenesis by abolishing the inhibitory function of RNF43 in Wnt signalling while maintaining its inhibitory function in p53 signalling. Our data suggest that RNF43 mutations cooperate with KRAS mutations to promote multi-step tumorigenesis via the Wnt-Ras-p53 axis in human colon cancers. Lastly, phosphomimetic substitutions of the serine trio restored the tumour suppressive activity of extracellular oncogenic mutants. Therefore, harnessing phospho-regulation of RNF43 might be a potential therapeutic strategy for tumours with RNF43 mutations.
Article, /631/67/1244, /631/80/86/2368, /631/80/474/2073, /692/4028/67/68, /692/4028/67/70, /13/95, /64/60, /64/116, /96/100, article
MEXT | Japan Society for the Promotion of Science (JSPS) (25430102, 16K07105, 19K07633, 16H06227, 15H04701, 17K19578, 16H05141, 15H04690, 18H02607)
MEXT | JST | Core Research for Evolutional Science and Technology (CREST) (JPMJCR15G4)
Ministry of Education, Culture, Sports, Science and Technology (MEXT) (26114006, 17H06301)
External DOI: https://doi.org/10.1038/s41467-020-18257-3
This record's URL: https://www.repository.cam.ac.uk/handle/1810/328081